PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34733901-8	2021	SCFAs can enhance the immune response by stimulating cytokine production (e.g. TNF-alpha, IL-2, IL-6, and IL-10) in the immune cells of the host.	Fatty Acids, Volatile	0-5	interleukin 10	Homo sapiens	106-111	
32383705-15	2020	As it was established the amount of bacteria producing short-chain fatty acids (SCFA) markedly decrease in T2-D, and treatment with SCFA reduced induction of TFN-alpha, IL-10 and IL-17 cytokines in contrast to IL-6, IFN-y and IL-22, without modification of their induction after using of SCFA.	Fatty Acids, Volatile	132-136	interleukin 10	Homo sapiens	169-174	
32383705-15	2020	As it was established the amount of bacteria producing short-chain fatty acids (SCFA) markedly decrease in T2-D, and treatment with SCFA reduced induction of TFN-alpha, IL-10 and IL-17 cytokines in contrast to IL-6, IFN-y and IL-22, without modification of their induction after using of SCFA.	Fatty Acids, Volatile	132-136	interleukin 10	Homo sapiens	169-174	
26398897-7	2015	In lipopolysaccharide (LPS)-stimulated PBMCs, SCFAs particularly butyrate down-regulated tumor necrosis factor alpha, interleukin (IL)-12, interferon gamma (IFN-gamma) and transforming growth factor beta-1 (TGF-beta1), and up-regulated IL-4, IL-10, while no significant effect was noted in non-LPS-stimulated PBMCs.	Fatty Acids, Volatile	46-51	interleukin 10	Homo sapiens	242-247